ArticleInflammatory intestinal diseases

Real-World Efficacy of Ustekinumab versus Vedolizumab for Ulcerative Colitis: Differences between Short- and Long-Term Outcomes Based on Endoscopic Remission.

Makoto Furuya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.